The potential of using enzyme-linked immunospot to diagnose cephalosporin-induced maculopapular exanthems

Acta Dermato-Venereologica

Volumn 93, Issue 1, 2013, Pages 66-69

  Tanvarasethee, Boonthorn ^a   Buranapraditkun, Supranee ^a   Klaewsongkram, Jettanong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Adverse drug reaction; Drug hypersensitivity; ELISPOT

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHEMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MACULOPAPULAR RASH; MALE; MEDICAL HISTORY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN TEST;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG HYPERSENSITIVITY; ENZYME-LINKED IMMUNOSPOT ASSAY; EXANTHEMA; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 84871699660     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1386     Document Type: Article

References (26)

1. Coenen S, Muller A, Adriaenssens N, Vankerckhoven V, Hendrickx E, goossens H. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009; 64: 200-205.
2. Madaan A, Li JT-C. Cephalosporin allergy. Immunol Allergy Clin North Am 2004; 24: 463-476, vi-vii.
3. Ibia EO, Schwartz RH, wiedermann BL. Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol 2000; 136: 849-854.
4. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006; 118: 555-562.
5. Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensiti-vity reactions to betalactams. Allergy 2009; 64: 183-193.
6. Padial A, Antunez C, Blanca-Lopez N, Fernandez TD, Cor-nejo-garcia JA, Mayorga C, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38: 822-828.
7. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974.
8. Luque I, Leyva L, José Torres M, Rosal M, Mayorga C, Segura JM, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 2001; 56: 611-618.
9. Sachs B, Erdmann S, Malte Baron J, Neis M, al Masaoudi T, Merk HF. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononu-clear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 2002; 32: 736-744.
10. Beeler A, Pichler wJ. In vitro tests of T cell-mediated drug hypersensitivity. Expert Rev Clin Immunol 2006; 2: 887-900.
11. Porebski G, Gschwend-Zawodniak A, Pichler wJ. In vitro diagnosis of T cell-mediated drug allergy. Clin Exp Allergy 2011; 41: 461-470.
12. Nyfeler B, Pichler wJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175-181.
13. Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007; 62: 1439-1444.
14. Ebo Dg, Leysen J, Mayorga C, Rozieres A, Knol EF, Ter-reehorst I. The in vitro diagnosis of drug allergy: status and perspectives. Allergy 2011; 66: 1275-1286.
15. Tassignon J, Burny w, Dahmani S, Zhou L, Stordeur P, Byl B, et al. Monitoring of cellular responses after vaccination against tetanus toxoid: comparison of the measurement of IFN-gamma production by ELISA, ELISPOT, fow cytometry and real-time PCR. J Immunol Methods 2005; 305: 188-198.
16. Rozieres A, Hennino A, Rodet K, gutowski MC, gunera-Saad N, Berard F, et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy 2009; 64: 534-542.
17. Beeler A, Engler O, gerber BO, Pichler wJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006; 117: 455-462.
18. Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler wJ. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 2000; 106: 1171-1176.
19. Posadas SJ, Leyva L, Torres MJ, Rodriguez JL, Bravo I, Rosal M, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106: 769-776.
20. Teraki Y, Shiohara T. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. J Allergy Clin Immunol 2003; 112: 609-615.
21. Lochmatter P, Beeler A, Kawabata TT, gerber BO, Pichler WJ. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersen-sitivity. Allergy 2009; 64: 1269-1278.
22. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
23. Romano A, guéant-Rodriguez R-M, Viola M, Amoghly F, gaeta F, Nicolas J-P, et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 2005; 35: 1234-1242.
24. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
25. Lopez S, Torres MJ, Rodríguez-Pena R, Blanca-Lopez N, Fernandez TD, Antunez C, et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 2009; 160: 259-265.
26. Vocanson M, Cluzel-Tailhardat M, Poyet g, Valeyrie M, Chavagnac C, Levarlet B, et al. Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens. J Invest Dermatol 2008; 128: 2119-2122.